Bausch Health Companies Inc. (NYSE:BHC) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET
Company Participants
Garen Sarafian – IR
Thomas Appio – CEO
Jean-Jacques Charhon – EVP & CFO
Conference Call Participants
Les Sulewski – Truist Securities
Doug Miehm – RBC Capital
Michael Freeman – Raymond James
Michael Nedelcovych – TD Cowen
Glen Santangelo – Jefferies
Operator
Greetings. Welcome to the Bausch Health Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note, this conference is being recorded.
I will now turn the conference over to your host, Garen Sarafian, Investor Relations of Bausch. You may begin.
Garen Sarafian
Good afternoon, and welcome to Bausch Health’s Fourth Quarter 2024 Earnings Call Conference Call. Participating in today’s call are Thomas Appio, Chief Executive Officer of Bausch Health; and JJ Charhon, Chief Financial Officer.
Before we begin, I’d like to remind you that our presentation today contains forward-looking information. We ask you to take a moment to read the forward-looking statement disclaimer at the beginning of the slides that accompany this presentation as it contains important information. Our actual results may vary materially from those expressed or implied in our forward-looking statements, and you should not place undue reliance on any forward-looking statements. Please refer to our SEC filings and our filings with the Canadian securities administrators for a list of some of the risk factors that cause our actual results to differ materially from our expectations.
We use non-GAAP financial measures to help investors understand our operating performance. Non-GAAP financial measures may not be comparable to similarly titled measures used by other companies to be considered along with but not as an alternative to measures calculated in accordance with GAAP. You will find reconciliations to
Read the full article here